nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Breast feeding—Tamoxifen—pancreatic cancer	0.0554	0.0554	CcSEcCtD
Gadobutrol—Application site pain—Fluorouracil—pancreatic cancer	0.0297	0.0297	CcSEcCtD
Gadobutrol—Hot flush—Tamoxifen—pancreatic cancer	0.015	0.015	CcSEcCtD
Gadobutrol—Menopausal symptoms—Tamoxifen—pancreatic cancer	0.0149	0.0149	CcSEcCtD
Gadobutrol—Parosmia—Docetaxel—pancreatic cancer	0.0146	0.0146	CcSEcCtD
Gadobutrol—Hot flush—Sunitinib—pancreatic cancer	0.0129	0.0129	CcSEcCtD
Gadobutrol—Menopausal symptoms—Sunitinib—pancreatic cancer	0.0128	0.0128	CcSEcCtD
Gadobutrol—Urine abnormality—Epirubicin—pancreatic cancer	0.0115	0.0115	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Epirubicin—pancreatic cancer	0.0108	0.0108	CcSEcCtD
Gadobutrol—Urine abnormality—Doxorubicin—pancreatic cancer	0.0106	0.0106	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.0102	0.0102	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Doxorubicin—pancreatic cancer	0.01	0.01	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00998	0.00998	CcSEcCtD
Gadobutrol—Parosmia—Epirubicin—pancreatic cancer	0.00982	0.00982	CcSEcCtD
Gadobutrol—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.00967	0.00967	CcSEcCtD
Gadobutrol—Visual impairment—Tamoxifen—pancreatic cancer	0.00937	0.00937	CcSEcCtD
Gadobutrol—Parosmia—Doxorubicin—pancreatic cancer	0.00908	0.00908	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.00905	0.00905	CcSEcCtD
Gadobutrol—Sweating increased—Irinotecan—pancreatic cancer	0.00835	0.00835	CcSEcCtD
Gadobutrol—Dysgeusia—Tamoxifen—pancreatic cancer	0.00829	0.00829	CcSEcCtD
Gadobutrol—Hypoaesthesia—Sunitinib—pancreatic cancer	0.00828	0.00828	CcSEcCtD
Gadobutrol—Injection site pain—Epirubicin—pancreatic cancer	0.0078	0.0078	CcSEcCtD
Gadobutrol—Hot flush—Docetaxel—pancreatic cancer	0.00733	0.00733	CcSEcCtD
Gadobutrol—Menopausal symptoms—Docetaxel—pancreatic cancer	0.00726	0.00726	CcSEcCtD
Gadobutrol—Injection site pain—Doxorubicin—pancreatic cancer	0.00722	0.00722	CcSEcCtD
Gadobutrol—Dysgeusia—Sunitinib—pancreatic cancer	0.0071	0.0071	CcSEcCtD
Gadobutrol—Dry mouth—Tamoxifen—pancreatic cancer	0.00705	0.00705	CcSEcCtD
Gadobutrol—Infection—Tamoxifen—pancreatic cancer	0.00686	0.00686	CcSEcCtD
Gadobutrol—Infection—Erlotinib—pancreatic cancer	0.00679	0.00679	CcSEcCtD
Gadobutrol—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00668	0.00668	CcSEcCtD
Gadobutrol—Visual impairment—Irinotecan—pancreatic cancer	0.00661	0.00661	CcSEcCtD
Gadobutrol—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00654	0.00654	CcSEcCtD
Gadobutrol—Convulsion—Sunitinib—pancreatic cancer	0.00628	0.00628	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.00626	0.00626	CcSEcCtD
Gadobutrol—Insomnia—Tamoxifen—pancreatic cancer	0.00625	0.00625	CcSEcCtD
Gadobutrol—Paraesthesia—Tamoxifen—pancreatic cancer	0.0062	0.0062	CcSEcCtD
Gadobutrol—Insomnia—Erlotinib—pancreatic cancer	0.00618	0.00618	CcSEcCtD
Gadobutrol—Dyspnoea—Tamoxifen—pancreatic cancer	0.00616	0.00616	CcSEcCtD
Gadobutrol—Dyspnoea—Erlotinib—pancreatic cancer	0.00609	0.00609	CcSEcCtD
Gadobutrol—Dry mouth—Sunitinib—pancreatic cancer	0.00603	0.00603	CcSEcCtD
Gadobutrol—Pain—Tamoxifen—pancreatic cancer	0.00591	0.00591	CcSEcCtD
Gadobutrol—Infection—Sunitinib—pancreatic cancer	0.00588	0.00588	CcSEcCtD
Gadobutrol—Pain—Erlotinib—pancreatic cancer	0.00584	0.00584	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00565	0.00565	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00559	0.00559	CcSEcCtD
Gadobutrol—Abnormal vision—Epirubicin—pancreatic cancer	0.00555	0.00555	CcSEcCtD
Gadobutrol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00546	0.00546	CcSEcCtD
Gadobutrol—Body temperature increased—Erlotinib—pancreatic cancer	0.0054	0.0054	CcSEcCtD
Gadobutrol—Abdominal pain—Erlotinib—pancreatic cancer	0.0054	0.0054	CcSEcCtD
Gadobutrol—Vertigo—Irinotecan—pancreatic cancer	0.00536	0.00536	CcSEcCtD
Gadobutrol—Insomnia—Sunitinib—pancreatic cancer	0.00535	0.00535	CcSEcCtD
Gadobutrol—Paraesthesia—Sunitinib—pancreatic cancer	0.00531	0.00531	CcSEcCtD
Gadobutrol—Dyspnoea—Sunitinib—pancreatic cancer	0.00527	0.00527	CcSEcCtD
Gadobutrol—Abnormal vision—Doxorubicin—pancreatic cancer	0.00514	0.00514	CcSEcCtD
Gadobutrol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00509	0.00509	CcSEcCtD
Gadobutrol—Pain—Sunitinib—pancreatic cancer	0.00506	0.00506	CcSEcCtD
Gadobutrol—Convulsion—Fluorouracil—pancreatic cancer	0.00495	0.00495	CcSEcCtD
Gadobutrol—Hot flush—Epirubicin—pancreatic cancer	0.00494	0.00494	CcSEcCtD
Gadobutrol—Menopausal symptoms—Epirubicin—pancreatic cancer	0.0049	0.0049	CcSEcCtD
Gadobutrol—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00487	0.00487	CcSEcCtD
Gadobutrol—Infection—Irinotecan—pancreatic cancer	0.00484	0.00484	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00484	0.00484	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00478	0.00478	CcSEcCtD
Gadobutrol—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00475	0.00475	CcSEcCtD
Gadobutrol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00473	0.00473	CcSEcCtD
Gadobutrol—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00472	0.00472	CcSEcCtD
Gadobutrol—Infection—Gemcitabine—pancreatic cancer	0.00472	0.00472	CcSEcCtD
Gadobutrol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00471	0.00471	CcSEcCtD
Gadobutrol—Abdominal pain—Sunitinib—pancreatic cancer	0.00468	0.00468	CcSEcCtD
Gadobutrol—Body temperature increased—Sunitinib—pancreatic cancer	0.00468	0.00468	CcSEcCtD
Gadobutrol—Diarrhoea—Erlotinib—pancreatic cancer	0.00468	0.00468	CcSEcCtD
Gadobutrol—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00467	0.00467	CcSEcCtD
Gadobutrol—Infection—Fluorouracil—pancreatic cancer	0.00464	0.00464	CcSEcCtD
Gadobutrol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00459	0.00459	CcSEcCtD
Gadobutrol—Hot flush—Doxorubicin—pancreatic cancer	0.00457	0.00457	CcSEcCtD
Gadobutrol—Visual impairment—Docetaxel—pancreatic cancer	0.00457	0.00457	CcSEcCtD
Gadobutrol—Dizziness—Tamoxifen—pancreatic cancer	0.00457	0.00457	CcSEcCtD
Gadobutrol—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00453	0.00453	CcSEcCtD
Gadobutrol—Dizziness—Erlotinib—pancreatic cancer	0.00452	0.00452	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00442	0.00442	CcSEcCtD
Gadobutrol—Insomnia—Irinotecan—pancreatic cancer	0.00441	0.00441	CcSEcCtD
Gadobutrol—Vomiting—Tamoxifen—pancreatic cancer	0.00439	0.00439	CcSEcCtD
Gadobutrol—Paraesthesia—Irinotecan—pancreatic cancer	0.00438	0.00438	CcSEcCtD
Gadobutrol—Hypersensitivity—Sunitinib—pancreatic cancer	0.00436	0.00436	CcSEcCtD
Gadobutrol—Rash—Tamoxifen—pancreatic cancer	0.00435	0.00435	CcSEcCtD
Gadobutrol—Dermatitis—Tamoxifen—pancreatic cancer	0.00435	0.00435	CcSEcCtD
Gadobutrol—Vomiting—Erlotinib—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Gadobutrol—Dyspnoea—Irinotecan—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Gadobutrol—Headache—Tamoxifen—pancreatic cancer	0.00433	0.00433	CcSEcCtD
Gadobutrol—Rash—Erlotinib—pancreatic cancer	0.00431	0.00431	CcSEcCtD
Gadobutrol—Dermatitis—Erlotinib—pancreatic cancer	0.0043	0.0043	CcSEcCtD
Gadobutrol—Insomnia—Gemcitabine—pancreatic cancer	0.00429	0.00429	CcSEcCtD
Gadobutrol—Headache—Erlotinib—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Gadobutrol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00426	0.00426	CcSEcCtD
Gadobutrol—Dyspnoea—Gemcitabine—pancreatic cancer	0.00423	0.00423	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Gadobutrol—Insomnia—Fluorouracil—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Gadobutrol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00419	0.00419	CcSEcCtD
Gadobutrol—Pain—Irinotecan—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Gadobutrol—Dyspnoea—Fluorouracil—pancreatic cancer	0.00416	0.00416	CcSEcCtD
Gadobutrol—Nausea—Tamoxifen—pancreatic cancer	0.0041	0.0041	CcSEcCtD
Gadobutrol—Pain—Gemcitabine—pancreatic cancer	0.00406	0.00406	CcSEcCtD
Gadobutrol—Nausea—Erlotinib—pancreatic cancer	0.00406	0.00406	CcSEcCtD
Gadobutrol—Diarrhoea—Sunitinib—pancreatic cancer	0.00405	0.00405	CcSEcCtD
Gadobutrol—Dysgeusia—Docetaxel—pancreatic cancer	0.00404	0.00404	CcSEcCtD
Gadobutrol—Pain—Fluorouracil—pancreatic cancer	0.00399	0.00399	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00398	0.00398	CcSEcCtD
Gadobutrol—Dizziness—Sunitinib—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Gadobutrol—Abdominal pain—Irinotecan—pancreatic cancer	0.00385	0.00385	CcSEcCtD
Gadobutrol—Body temperature increased—Irinotecan—pancreatic cancer	0.00385	0.00385	CcSEcCtD
Gadobutrol—Vomiting—Sunitinib—pancreatic cancer	0.00376	0.00376	CcSEcCtD
Gadobutrol—Body temperature increased—Gemcitabine—pancreatic cancer	0.00375	0.00375	CcSEcCtD
Gadobutrol—Rash—Sunitinib—pancreatic cancer	0.00373	0.00373	CcSEcCtD
Gadobutrol—Dermatitis—Sunitinib—pancreatic cancer	0.00373	0.00373	CcSEcCtD
Gadobutrol—Headache—Sunitinib—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Gadobutrol—Pollakiuria—Epirubicin—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Gadobutrol—Body temperature increased—Fluorouracil—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Gadobutrol—Palpitations—Docetaxel—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Gadobutrol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00359	0.00359	CcSEcCtD
Gadobutrol—Convulsion—Docetaxel—pancreatic cancer	0.00358	0.00358	CcSEcCtD
Gadobutrol—Nausea—Sunitinib—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Gadobutrol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Gadobutrol—Dry mouth—Docetaxel—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Gadobutrol—Pollakiuria—Doxorubicin—pancreatic cancer	0.00341	0.00341	CcSEcCtD
Gadobutrol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00337	0.00337	CcSEcCtD
Gadobutrol—Infection—Docetaxel—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Gadobutrol—Diarrhoea—Irinotecan—pancreatic cancer	0.00333	0.00333	CcSEcCtD
Gadobutrol—Diarrhoea—Gemcitabine—pancreatic cancer	0.00325	0.00325	CcSEcCtD
Gadobutrol—Dizziness—Irinotecan—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Gadobutrol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Gadobutrol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Gadobutrol—Vomiting—Irinotecan—pancreatic cancer	0.0031	0.0031	CcSEcCtD
Gadobutrol—Dizziness—Fluorouracil—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Gadobutrol—Visual impairment—Epirubicin—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Gadobutrol—Rash—Irinotecan—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Gadobutrol—Dermatitis—Irinotecan—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Gadobutrol—Headache—Irinotecan—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Gadobutrol—Insomnia—Docetaxel—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Gadobutrol—Paraesthesia—Docetaxel—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Gadobutrol—Vomiting—Gemcitabine—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Gadobutrol—Dyspnoea—Docetaxel—pancreatic cancer	0.003	0.003	CcSEcCtD
Gadobutrol—Rash—Gemcitabine—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Gadobutrol—Dermatitis—Gemcitabine—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Gadobutrol—Headache—Gemcitabine—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Gadobutrol—Vomiting—Fluorouracil—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Gadobutrol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Gadobutrol—Rash—Fluorouracil—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Gadobutrol—Dermatitis—Fluorouracil—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Gadobutrol—Headache—Fluorouracil—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Gadobutrol—Nausea—Irinotecan—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Gadobutrol—Pain—Docetaxel—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Gadobutrol—Visual impairment—Doxorubicin—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Gadobutrol—Nausea—Gemcitabine—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Gadobutrol—Nausea—Fluorouracil—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Gadobutrol—Dysgeusia—Epirubicin—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Gadobutrol—Abdominal pain—Docetaxel—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Body temperature increased—Docetaxel—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Dysgeusia—Doxorubicin—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Gadobutrol—Vertigo—Epirubicin—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Gadobutrol—Hypersensitivity—Docetaxel—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Gadobutrol—Palpitations—Epirubicin—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Convulsion—Epirubicin—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Gadobutrol—Dry mouth—Epirubicin—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Gadobutrol—Vertigo—Doxorubicin—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Gadobutrol—Diarrhoea—Docetaxel—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Gadobutrol—Palpitations—Doxorubicin—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Gadobutrol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Gadobutrol—Infection—Epirubicin—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Gadobutrol—Convulsion—Doxorubicin—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Gadobutrol—Dizziness—Docetaxel—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Gadobutrol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Gadobutrol—Dry mouth—Doxorubicin—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Gadobutrol—Vomiting—Docetaxel—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Gadobutrol—Rash—Docetaxel—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Gadobutrol—Dermatitis—Docetaxel—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Gadobutrol—Headache—Docetaxel—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Gadobutrol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Gadobutrol—Infection—Doxorubicin—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Gadobutrol—Insomnia—Epirubicin—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Gadobutrol—Paraesthesia—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Gadobutrol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Gadobutrol—Dyspnoea—Epirubicin—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Gadobutrol—Nausea—Docetaxel—pancreatic cancer	0.002	0.002	CcSEcCtD
Gadobutrol—Pain—Epirubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Gadobutrol—Insomnia—Doxorubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Gadobutrol—Paraesthesia—Doxorubicin—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Gadobutrol—Dyspnoea—Doxorubicin—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Gadobutrol—Pain—Doxorubicin—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Gadobutrol—Abdominal pain—Epirubicin—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Gadobutrol—Body temperature increased—Epirubicin—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Gadobutrol—Hypersensitivity—Epirubicin—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Gadobutrol—Body temperature increased—Doxorubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Gadobutrol—Abdominal pain—Doxorubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Gadobutrol—Diarrhoea—Epirubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Gadobutrol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Gadobutrol—Dizziness—Epirubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Gadobutrol—Vomiting—Epirubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Gadobutrol—Diarrhoea—Doxorubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Gadobutrol—Rash—Epirubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Gadobutrol—Dermatitis—Epirubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Gadobutrol—Headache—Epirubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Gadobutrol—Dizziness—Doxorubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Gadobutrol—Nausea—Epirubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Gadobutrol—Vomiting—Doxorubicin—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Gadobutrol—Rash—Doxorubicin—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Gadobutrol—Dermatitis—Doxorubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Gadobutrol—Headache—Doxorubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Gadobutrol—Nausea—Doxorubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
